GENOTECH CORP. Logo

GENOTECH CORP.

A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.

066830 | KO

Overview

Corporate Details

ISIN(s):
KR7066830001
LEI:
Country:
South Korea
Address:
대전광역시 유성구 가정북로 26-69, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Genotech Corp. is a South Korea-based biotechnology company that engages in the production and sale of pharmaceutical and biological products. The company's core activities include providing products and services for gene synthesis, genome analysis, and biopharmaceuticals. It also manufactures basic pharmaceutical substances and biological agents, offering related technical and academic services to both domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-19 00:00
Regulatory News Service
기업설명회(IR)개최결과
Korean 6.6 KB
2025-06-09 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.3 KB
2025-03-31 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-03-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 89.5 KB
2025-03-24 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 19.9 KB
2025-03-14 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 320.9 KB
2025-03-11 00:00
Audit Report / Information
감사보고서제출
Korean 9.7 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 103.5 KB
2025-02-25 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 11.6 KB
2024-12-06 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-13 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2024-10-30 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2024-09-05 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 57.1 KB
2024-08-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 85.7 KB
2024-08-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.0 KB

Automate Your Workflow. Get a real-time feed of all GENOTECH CORP. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENOTECH CORP.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENOTECH CORP. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea
007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea
293780
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden
APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea
291650
Aptevo Therapeutics Inc. Logo
Developing multi-specific antibody immunotherapies for hematologic and solid tumor cancers.
United States of America
APVO
Aptorum Group Ltd Logo
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Develops oral film drugs for CNS disorders and severe allergies.
United States of America
AQST
Arbutus Biopharma Corp Logo
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
United States of America
ABUS
Arcellx, Inc. Logo
Engineering controllable cell therapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway
ABS

Talk to a Data Expert

Have a question? We'll get back to you promptly.